BRIEF-AMAG Pharmaceuticals says FDA accepted SNDA for Feraheme label expansion

March 6 (Reuters) - AMAG Pharmaceuticals Inc :

* Announces FDA acceptance of supplemental new drug application for feraheme

label expansion to include iron deficiency anemia patients who cannot take

oral iron

* Says FDA has set October 21, 2013 as a target date for completion of their

review * Source text

* Further company coverage

((Bangalore Newsroom; +1 646 223 8780))

View the original article here